The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.

The long-term safety of ibrutinib was proven in patients with newly diagnosed or relapsed or refractory (R/R) chronic ...

Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced European CE mark approval of the Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter for the treatment of cardiac ...

Johnson & Johnson halted the limited rollout of its Varipulse pulsed field ablation system on Jan. 5 to “investigate the root causes of four reported neurovascular events in the U.S. external ...

This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...

Take control of your health and participate in K-State Research and Extension’s upcoming Hypertension Awareness and ...

During the 66th American Society of Hematology Annual Meeting and Exposition, investigators revealed early-phase 1 data evaluating various BTK degraders that leverage different strategies to overcome ...

A letter signed by more than 17,000 doctors urges Senators to reject Robert F. Kennedy Jr. as HHS secretary, calling the ...

Participants are expected to attend the Kick-Off meeting on Tuesday, February 4, 2025, from 6:00 pm – 7:00 pm. Participants ...

The integration of artificial intelligence (AI) into healthcare has opened new frontiers for improving patient care and ...

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today ...